These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 12093082)

  • 41. Disrupted striatal neuron inputs and outputs in Huntington's disease.
    Reiner A; Deng YP
    CNS Neurosci Ther; 2018 Apr; 24(4):250-280. PubMed ID: 29582587
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mice deficient in L-12/15 lipoxygenase show increased vulnerability to 3-nitropropionic acid neurotoxicity.
    He Y; Akumuo RC; Yang Y; Hewett SJ
    Neurosci Lett; 2017 Mar; 643():65-69. PubMed ID: 28229935
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 3-Nitropropionic acid induces a spectrum of Huntington's disease-like neuropathology in rat striatum.
    Vis JC; Verbeek MM; De Waal RM; Ten Donkelaar HJ; Kremer HP
    Neuropathol Appl Neurobiol; 1999 Dec; 25(6):513-21. PubMed ID: 10632901
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neuronal vulnerability in mouse models of Huntington's disease: membrane channel protein changes.
    Ariano MA; Wagle N; Grissell AE
    J Neurosci Res; 2005 Jun; 80(5):634-45. PubMed ID: 15880743
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Deficits induced by quinolinic acid lesion to the striatum in a position discrimination and reversal task are ameliorated by permanent and temporary lesion to the globus pallidus: a potential novel treatment in a rat model of Huntington's disease.
    Joel D; Ayalon L; Tarrasch R; Weiner I
    Mov Disord; 2003 Dec; 18(12):1499-507. PubMed ID: 14673887
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Creatine reduces 3-nitropropionic-acid-induced cognitive and motor abnormalities in rats.
    Shear DA; Haik KL; Dunbar GL
    Neuroreport; 2000 Jun; 11(9):1833-7. PubMed ID: 10884028
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 3-Nitropropionic acid neurotoxicity: visualization by silver staining and implications for use as an animal model of Huntington's disease.
    Miller PJ; Zaborszky L
    Exp Neurol; 1997 Jul; 146(1):212-29. PubMed ID: 9225755
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Donor age dependent graft development and recovery in a rat model of Huntington's disease: histological and behavioral analysis.
    Schackel S; Pauly MC; Piroth T; Nikkhah G; Döbrössy MD
    Behav Brain Res; 2013 Nov; 256():56-63. PubMed ID: 23916743
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The adenosine A1 receptor agonist adenosine amine congener exerts a neuroprotective effect against the development of striatal lesions and motor impairments in the 3-nitropropionic acid model of neurotoxicity.
    Blum D; Gall D; Galas MC; d'Alcantara P; Bantubungi K; Schiffmann SN
    J Neurosci; 2002 Oct; 22(20):9122-33. PubMed ID: 12388620
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Calpain is a major cell death effector in selective striatal degeneration induced in vivo by 3-nitropropionate: implications for Huntington's disease.
    Bizat N; Hermel JM; Boyer F; Jacquard C; Créminon C; Ouary S; Escartin C; Hantraye P; Kajewski S; Brouillet E
    J Neurosci; 2003 Jun; 23(12):5020-30. PubMed ID: 12832525
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cellular localization of huntingtin in striatal and cortical neurons in rats: lack of correlation with neuronal vulnerability in Huntington's disease.
    Fusco FR; Chen Q; Lamoreaux WJ; Figueredo-Cardenas G; Jiao Y; Coffman JA; Surmeier DJ; Honig MG; Carlock LR; Reiner A
    J Neurosci; 1999 Feb; 19(4):1189-202. PubMed ID: 9952397
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neurturin gene therapy improves motor function and prevents death of striatal neurons in a 3-nitropropionic acid rat model of Huntington's disease.
    Ramaswamy S; McBride JL; Herzog CD; Brandon E; Gasmi M; Bartus RT; Kordower JH
    Neurobiol Dis; 2007 May; 26(2):375-84. PubMed ID: 17336076
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease.
    Brouillet E; Jacquard C; Bizat N; Blum D
    J Neurochem; 2005 Dec; 95(6):1521-40. PubMed ID: 16300642
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Plastic and behavioral abnormalities in experimental Huntington's disease: a crucial role for cholinergic interneurons.
    Picconi B; Passino E; Sgobio C; Bonsi P; Barone I; Ghiglieri V; Pisani A; Bernardi G; Ammassari-Teule M; Calabresi P
    Neurobiol Dis; 2006 Apr; 22(1):143-52. PubMed ID: 16326108
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Perseverative behavior underlying attentional set-shifting deficits in rats chronically treated with the neurotoxin 3-nitropropionic acid.
    El Massioui N; Ouary S; Chéruel F; Hantraye P; Brouillet E
    Exp Neurol; 2001 Nov; 172(1):172-81. PubMed ID: 11681849
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Major strain differences in response to chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid in rats: implications for neuroprotection studies.
    Ouary S; Bizat N; Altairac S; Ménétrat H; Mittoux V; Condé F; Hantraye P; Brouillet E
    Neuroscience; 2000; 97(3):521-30. PubMed ID: 10828534
    [TBL] [Abstract][Full Text] [Related]  

  • 57. IGF-1 exacerbates the neurotoxicity of the mitochondrial inhibitor 3NP in rats.
    Escartin C; Boyer F; Bemelmans AP; Hantraye P; Brouillet E
    Neurosci Lett; 2007 Oct; 425(3):167-72. PubMed ID: 17868993
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4/5 prevent the death of striatal projection neurons in a rodent model of Huntington's disease.
    Pérez-Navarro E; Canudas AM; Akerund P; Alberch J; Arenas E
    J Neurochem; 2000 Nov; 75(5):2190-9. PubMed ID: 11183872
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preferential interneuron survival in the transition zone of 3-NP-induced striatal injury in rats.
    Mu S; OuYang L; Liu B; Zhu Y; Li K; Zhan M; Liu Z; Jia Y; Lei W; Reiner A
    J Neurosci Res; 2011 May; 89(5):744-54. PubMed ID: 21337370
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Striatal, pallidal, and pars reticulata evoked inhibition of nigrostriatal dopaminergic neurons is mediated by GABA(A) receptors in vivo.
    Paladini CA; Celada P; Tepper JM
    Neuroscience; 1999 Mar; 89(3):799-812. PubMed ID: 10199614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.